If the third vaccine dose was administered 16 weeks or less before infection, healthcare providers had lower odds of reporting respiratory symptoms.
COVID vaccine protects against symptoms 6 weeks after infection, study shows
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows